Carducci, M A
~ 600  Ergebnisse:
Personensuche X
?
 
?
 
?
3

Debridement, antibiotics and implant retention (DAIR): An e..:

Tatarelli, P. ; Romani, T. ; Santoro, V....
Journal of Infection and Chemotherapy.  27 (2021)  8 - p. 1162-1168 , 2021
 
?
4

Emerging Prognostic Groups Across the Spectrum of Metastati..:

Sutera, P. ; Van der Eecken, K. ; Kishan, A.U....
International Journal of Radiation Oncology*Biology*Physics.  111 (2021)  3 - p. e294-e295 , 2021
 
?
 
?
6

Modes of Failure Following Metastasis Directed Therapy in P..:

Taparra, K. ; Deek, M.P. ; Dao, D....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. e869-e870 , 2020
 
?
7

Metastasis Directed Therapy Prolongs Efficacy of Systemic T..:

Deek, M.P. ; Taparra, K. ; Phillips, R....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. e893-e894 , 2020
 
?
8

Improved identification of patients with oligometastatic cl..:

Meyer, A.R. ; Rowe, S. ; Carducci, M....
European Urology Supplements.  18 (2019)  1 - p. e1930 , 2019
 
?
9

Primary Outcomes of a Phase II Randomized Trial of Observat..:

Phillips, R. ; Lim, S.J. ; Shi, W.Y....
International Journal of Radiation Oncology*Biology*Physics.  105 (2019)  3 - p. 681 , 2019
 
?
 
?
11

Bone turnover biomarkers identify unique prognostic risk gr..:

Lara Jr., P.N. ; Plets, M. ; Tangen, C....
Cancer Treatment and Research Communications.  16 (2018)  - p. 18-23 , 2018
 
?
12

A review of pomegranate in prostate cancer:

Paller, C J ; Pantuck, A ; Carducci, M A
Prostate Cancer and Prostatic Diseases.  20 (2017)  3 - p. 265-270 , 2017
 
?
14

Germline mutations in ATM and BRCA1/2 distinguish risk for ..:

Na, R. ; Zheng, S.L. ; Han, M....
European Urology Supplements.  16 (2017)  3 - p. e832-e833 , 2017
 
1-15